Global Topical Contraceptive Market 2017-2021
About Topical Contraceptive
Topical contraceptives are contraceptive patches that release hormones, estrogen, and progestin to prevent pregnancies. They work in a similar manner as oral contraceptives. Various temporary and permanent contraceptive methods and devices for women are available in the market. Permanent methods such as sterilization are considered the most effective as they eliminate the chances of pregnancy.
Technavio’s analysts forecast the global topical contraceptive market to grow at a CAGR of 2% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global topical contraceptive market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of topical contraceptives.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Topical contraceptive market 2017-2021
Technavio recognizes the following companies as the key players in the global topical contraceptive market: ALLERGAN, Mylan, Merck Millipore, Pfizer and Teva Pharmaceuticals.
Other Prominent Vendors in the market are: Afaxys, Agile Therapeutics, Ansell, Bayer Pharma, Caya, Ferring Pharmaceuticals, Female Health, Fuji Latex, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Lupin Pharmaceuticals, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser and Syzygy Healthcare.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing demand for other contraceptive methods. Other contraceptive methods are becoming more popular among women than topical contraceptives. This is because of the increased advantages provided by them. For instance, the demand for IUD, sterilization, female condoms, and oral pills is increasing.”
According to the report, one driver in the market is proliferation of strategic initiatives. Innovation and effectiveness of female contraceptives are the key to market growth. Several vendors are entering into strategic alliances and investing in R&D for product innovation and better financial stability, thereby developing the latest products with better efficiency, safety, and protection.
Further, the report states that one challenge in the market is high preference for other types of contraceptives. Due to limited advantages provided by topical contraceptives, they are less popular among females. This has led to an increased preference for other types of female contraceptives devices such as IUD, subdermal contraceptives, vaginal ring, female condom; and female contraceptive drugs such as birth control pill and emergency pill.
ALLERGAN, Mylan, Merck Millipore, Pfizer, Teva Pharmaceuticals, Afaxys, Agile Therapeutics, Ansell, Bayer Pharma, Caya, Ferring Pharmaceuticals, Female Health, Fuji Latex, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Lupin Pharmaceuticals, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser and Syzygy Healthcare.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook